Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT05774262

Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block

Led by American Heart of Poland · Updated on 2024-03-18

300

Participants Needed

2

Research Sites

173 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The TELE-SPACER study is a multicenter, noncommercial, physician-initiated, proof-of-concept, prospective, randomized, controlled, unblinded clinical trial and registry designed to compare two methods of treatment of patients with functional Atrio-Ventricular Block (AVB): the guidelines-recommended elective pacemaker (PM) therapy vs cardiovascular autonomic tests (CAT), electrophysiologic assessment (EPS) with referral to cardioneuroablation (CNA) and reevaluation of indications for PM therapy. The main questions TELE-SPACER aims to answer are: * Can the investigators successfully treat functional AVB without implantable device (PM)? * Can the investigators prove the feasibility and safety and demonstrate non-inferiority of CNA procedure in patients with functional AVB, avoiding long-term permanent pacing, its limitations, complications and costs ? The TELE-SPACER trial will validate the European Society of Cardiology (ESC) recommendations (level C of evidence: expert opinion) for elective PM implantation and will introduce CNA as effective treatment in the functional AVB patient population. Functional AVB - defined as a persistent or paroxysmal AVB with a positive results of atropine test

CONDITIONS

Official Title

Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent to participate in the study
  • Age 18-75 years
  • Indication for elective pacemaker implantation according to ESC guidelines for isolated paroxysmal, persistent, or reflex atrioventricular block including symptomatic first degree AVB (above 300 msec), symptomatic Mobitz type I second degree AVB, AVB 2:1 not during sleep, Mobitz II advanced 2nd degree AVB or complete block, advanced AVB during atrial fibrillation not during sleep, and reflex syncope in patients over 40 years with documented pauses within AVB mechanism
Not Eligible

You will not qualify if you...

  • Implanted pacemaker, ICD, or CRT device
  • Sinus node dysfunction with indication for pacemaker implantation
  • Planned ablation of the atrioventricular junction
  • Severe prolonged bradycardia in advanced AVB requiring intravenous drugs and temporary pacing
  • Status post cardiac surgery
  • Acute myocardial infarction or heart failure unrelated to bradycardia
  • Status post percutaneous valvular intervention or ablation
  • Acute infection or other contraindications to percutaneous procedures or pacemaker implantation
  • Pregnancy, nursing, or planned pregnancy within 12 months
  • Decompensated chronic diseases such as endocrine or electrolyte disorders
  • Advanced cardiomyopathies or ventricular arrhythmias requiring ICD implantation
  • Persistent right or left bundle branch block
  • Musculoskeletal diseases with separate indications for pacemaker implantation
  • Contraindications to study procedures
  • Mental illness or cognitive limitations preventing participation or telemedicine use
  • Any other abnormalities considered contraindications by the Principal Investigator due to safety or data interpretation concerns

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

American Heart of Poland

Dąbrowa Górnicza, Poland, 41-300

Actively Recruiting

2

American Heart of Poland

Mielec, Poland, 39-300

Actively Recruiting

Loading map...

Research Team

S

Sebastian M Stec, MD, PhD

CONTACT

E

Edyta Stodolkiewicz-Nowarska, MD PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here